Treating severe COVID-19 associated secondary bacterial infections with Phage Therapy under the Declaration of Helsinki

Acronym

COVID-19_Phage

Description of the granted funding

Bacteriophages are viruses that infect and kill bacterial cells. SARS-Cov-2 infektion weakens the innate immune defense of lungs, which makes the patient susceptible to sometimes lethal bacterial pneumonia. Hospital acquired bacterial infections are often caused by pathogens that are resistant to antibiotics, which leaves very few treatment options. In the proposed project, we will isolate and prepare bacteriophages against the most problematic antibiotic resistant bacterial pathogens causing secondary infections in severe cases of COVID-19.
Show more

Starting year

2020

End year

2022

Granted funding


Matti Jalasvuori Orcid -palvelun logo
188 217 €

Role in consortium of the Academy of Finland

Leader

Other consortium parties

Partner
University of Helsinki (336519)
203 719 €

Funder

Research Council of Finland

Funding instrument

Targeted Academy projects

Other information

Funding decision number

336518

Research fields

Kliiniset lääketieteet

Themes

Lisätalousarvio III 2020

Identified topics

covid, pandemic, vaccines